SCPS
Scopus BioPharma Inc. Common Stock
SCPS
SCPS
Delisted
SCPS was delisted on the 16th of December, 2022.
4 hedge funds and large institutions have $639K invested in Scopus BioPharma Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
4
Holders Change
+4
Holders Change %
–
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VF
1
Virtu Financial
New York
|
$242K |
| 2 |
SSA
2
Schonfeld Strategic Advisors
New York
|
$223K |
| 3 |
3
First Manhattan
New York
|
$154K |
| 4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$20K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $242K | 16,280 | +16,280 | New |
|
|
SSA
2
Schonfeld Strategic Advisors
New York
| $223K | 15,000 | +15,000 | New |
|
|
3
First Manhattan
New York
| $154K | 10,400 | +10,400 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $20K | 1,370 | +1,370 | New |
|
|
CFGS
5
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|